Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Lenalidomide + Blinatumomab for Lymphoma
Recruiting1 awardPhase 1
Sacramento, California
This trial is testing the side effects and best dose of lenalidomide and blinatumomab when given together to patients with non-Hodgkin lymphoma that has returned after a period of improvement.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service